ARTICLE | Company News
Alpha-Beta other research news
January 2, 1996 8:00 AM UTC
The FDA has given ABTI permission to use Betafectin PGG-glucan manufactured at the company’s new commercial facility in its ongoing Phase III trial for the treatment of post-operative infection in high-risk surgery patients. ...